All about asthma
Patients are faced with many choices when finding a physician to help them treat and control their asthma. Here at the College, we know that the best experts in asthma are our allergists. It’s our members that have the expertise to develop treatment plans that will work with any patient’s lifestyle. If you’re looking to offer the latest and best asthma treatments to your patients, look no further than our 2018 Annual Scientific Meeting – featuring many sessions covering asthma diagnosis, treatments and the latest research. Check out the sessions at the meeting that are all about asthma:
- What to Do When Your Patients Reach the Yellow Zone, Nov 16, 3:00 – 4:30 pm – This clinical conundrum session features three short talks with a prolonged Q&A. First we will cover variability in perception of dyspnea, real world non-adherence and a proposed mechanism of dose escalation. Next, learn how to escalate dosages of ICS to prevent exacerbations and how to dose differently for children versus adults. Then hear if dynamic dosing is ready to be used in your practice. Speakers are John Oppenheimer, MD, FACAAI, Daniel Jackson, MD, and David Lang, MD, FACAAI.
- Presidential plenary: Network Studies: Pulling It All Together for Adults and Kids, Nov. 17, 8:00 – 9:30 am – Clinical trials and research networks have identified many breakthroughs in the diagnosis and management of asthma in children and adults. As the body of evidence continues to grow, it is more challenging than ever to take knowledge from these studies and apply it to clinical guidelines and ultimately implement it into clinical practice. This session will highlight how network studies have impacted our understanding of asthma management and offer practical tips on how health care providers can use this information to better inform their patients. Speakers are William Busse, MD, FACAAI, Stanley Szefler, MD, Leonard Bacharier, MD, FACAAI and Stephen Peters, MD, PhD.
- Expanding Our Role in the Community: Treating COPD in the Allergy-Immunology Practice Setting, Nov. 17, 10:00 – 11:30 am – With COPD being the third leading cause of death in the U.S., allergists are in a unique position to be at the forefront of COPD care. Attend this session to learn about the revised COPD GOLD guidelines, understand the new ACO guidelines, and learn about humoral immunodeficiency in COPD patients with frequent exacerbations. Speakers for this clinical conundrum session are Mario Castro, MD, MPH, Bryan Martin, DO, FACAAI, and Antoine Azar, MD.
- PBL: An Inner-city Child With Uncontrolled Asthma – Learning to Care for the Underserved Child – Lost Opportunities, Nov. 17, 1:00 – 2:30 pm – This is a problem-based learning session, where a case will be discussed followed by a real-time needs assessment based on that discussion. Speakers will then cover how to navigate the diagnosis and treatment of under-served inner-city populations, with an emphasis on how to provide best practice information needed for the medical visit. Speakers are Don Bukstein, MD, FACAAI, Leonard Bacharier, MD, FACAAI, and Lila Kertz, MSN, RN, CPNP, AE-C
- Lung Function Testing: Spirometry, FeNo and Challenges Done Right!, Nov. 17, 3:00 – 4:30 pm – In this practical applications seminar, attendees will review previous and current American Thoracic Society spirometry guidelines and use cases to highlight the need for a standardized approach in order to deliver reliable, high-quality, precise care to patients. Then hear if all offices should be measuring FeNo and learn how to conduct exercise and/or methacholine challenges in the office. Speakers are Mario Castro, MD, MPH, Kaiser Lim, MD, and Donald Cockroft, MD.
- Improving Severe Asthma Control Through Comprehensive Patient Assessment and Tailored Treatment Selection, Nov. 18, 6:30 – 7:55 am – Challenge yourself to wake up a little earlier to attend this great symposium, focusing on interventions that improve disease awareness and understanding of treatment-related issues (such as medication adherence and proper device technique). Review strategies for promoting self-management among patients with asthma, including identification of logistical and psychological obstacles to effective disease management, development of action plans and participation in structured support programs. Speakers TBD
- Spectrum of Dysfunctional Breathing, Nov. 18, 10:00 – 11:30 am – Study up on dysfunctional breathing in children and adults, how to recognize asthma mimickers, treat exercised-induced shortness of breath and medical versus non-medical therapies for dysfunctional breathing. Discussions will also cover VCD, EIA HVS, EILO, dynamic airway collapse and more. Speakers are Stephen Tilles, MD, FACAAI, past ACAAI president, and J. Todd Olin, MD.
- How to Assess Growth and Fracture Risk in the Steroid-treated Patient, Nov. 18, 1:00- 2:30 pm – Oral and high-dose inhaled corticosteroids increase the risk of poor growth in children and osteoporotic fractures in adults – but studies show that clinicians often do not evaluate and treat these risks. Attend this session to discover easy-to-use tools to assess height and fracture risk, nutrition, bone integrity and growth, as well as how to protect patients treated with corticosteroids. Speakers are Carina Venter, PhD, RD, Marion Groetch, RDN, Joy Wu, MD, PhD, and Marvat Nassef, MD, FACAAI.
- Shifting Paradigms in Management of Severe Asthma: Pathogenesis, Phenotypes and Personalized Medicine, Nov. 18, 1:00 – 2:30 pm – During this symposium, experts will present a clinically-focused overview of asthma, including pathophysiology, clinical diagnosis, risk stratification and patient-centric clinical management of disease. Dive into asthma phenotypes, current and emerging biologics and multi-disciplinary approaches to managing severe asthma. Learn the practicalities of how to do this in-office using shared-decision making tools and risk management. Speakers are Stephen Peters, MD, PhD, Mark FitzGerald, MD, and William Busse, MD, FACAAI.